We Don't Discover Cures, We Help YOU Engineer Them

AI-powered precision medicine platform that transforms genomic data into actionable therapeutic intelligence.

Initializing Editor...
1,368 aa
0.92
2

Trusted By Leading Organizations

CrisPRO.ai builds trust through transparency and auditability. World-class research institutions and technology leaders trust us to accelerate breakthrough discoveries with honest limitations and evidence-backed recommendations.

American Association for Cancer Research logo

American Association for Cancer Research

Leading cancer research organization advancing the prevention and cure of cancer

Visit Website

Interested in partnering with CrisPRO.ai?

Partner With Us

You Bring the Science, We Bring the AI Engineering

Validated in-silico predictions for variant impact, drug fit, and CRISPR design.

📊 53,210+ variants validated
🏆 State-of-the-art on ClinVar
🧬 No training required
Key Differentiator

SAE Explainability

32,768 learned biological features explain every prediction

100%
Transparent AI
32,768 SAE features
SOTA

ClinVar Validation

We Eliminate Failure at the Source.

95.7%
AUROC
53,210 variants validated
Clinical Grade

BRCA1/2 Precision

We eliminate the failure of clinical translation

95.0%
BRCA1 AUROC
3,893 variants analyzed
4x Better

Therapeutic Design

we design viable candidates from day one, not by chance

70%
Pfam-hit Rate
vs 18% previous models
Contract Ready

ROI for Biotechs

We Eliminate the Failure of Bankruptcy

80%
Cost Reduction
$2.5M → $500K per target

See All Performance Metrics

Explore our complete validation results, benchmark comparisons, and business impact analysis.Everything you need for due diligence and contract negotiations.

🔬 Peer-reviewed validation • 📊 Real-world benchmarks • 💼 Contract-ready analysis

Our Capabilities

Comprehensive in-silico tools for research oncology, from variant analysis to therapeutic guidance

Will It Work For Me?

Clinical Decision Support

Efficacy Confidence:70-85%%
Toxicity Prevention:100%%
Trial Match %:96.600%

Universal Hypothesis Testing

Research Acceleration

Diseases Supported:50.000+
Compounds Queryable:110M+
Hypothesis Validation:Hours

Design Precision Interventions

Therapeutic Design

Guides Validated:100%%
Structural Confidence (pLDDT):70.000
FDA Docs Generated:Complete

Multi-Modal AI Validation

Platform Intelligence

S/P/E Weighting:30/40/30
Insights Chips:4.000
Audit Trails:Complete

Ask Questions Naturally

Conversational AI

Natural Language Parsing:High
Context Awareness:Sporadic-Aware
Multi-Intent Handling:Seamless

Production-Ready SaaS

Enterprise Platform

Database Schema:9.000tables
Pricing Tiers:3.000
Admin Controls:Complete

From 90% Failure to Predictable Success

Transform your drug development pipeline from gambling to engineering with our 3-stage in-silico platform. Every stage includes SAE explainability—see exactly what the AI is thinking.👇 Scroll down to try each stage live with interactive demos.

Stage 1: Target Identification & Validation

From months of exploration to 60-second conquest

❌ The Problem
The Exploratory Phase Bottleneck
Cost: $2.5M per target
Time: 18 months average
Failure Rate: 85% false positives
✅ Our Solution
60-Second In-Silico Conquest

Mathematical proof of functional disruption + Achilles' heel confirmation

Business Impact
Cost Reduction
99.8%
Time Reduction
72x faster
Success Rate
6x improvement
Validated Performance
BRCA1 AUROC95.0%
ClinVar SOTA95.7%

Stage 2: Lead Discovery & Optimization

We don't discover leads; we engineer them

❌ The Problem
The Screening Bottleneck
Cost: Millions of molecules screened
Time: 2-3 years optimization
Failure Rate: 99.9% candidates fail
✅ Our Solution
Zeta Forge: Therapeutic Engineering

First-principles design with embedded optimization

Business Impact
Cost Reduction
95%
Time Reduction
Years → Hours
Success Rate
Multiple candidates per command
Validated Performance
Pfam-hit Rate70%
Structural ValidationAlphaFold 3 confirmed

Stage 3: Pre-Clinical Confirmation

From expensive wet-lab to near-zero-cost in-silico trial

❌ The Problem
The Validation Gate
Cost: Expensive wet-lab confirmation
Time: 6-12 months
Failure Rate: 70% fail at this stage
✅ Our Solution
In-Silico Trial Validation

Cellular-level simulation + structural proof of mechanism

Business Impact
Cost Reduction
90%
Time Reduction
Months → Days
Success Rate
High-certainty candidates only
Validated Performance
DMS CorrelationStrong correlation
Structural OracleAlphaFold 3 integration

Discovery vs. Engineering

The fundamental shift from a game of chance to a discipline of creation.

The Old Way: A Funnel

Low-probability screening

Millions of Molecules

Searching...

0.0 months
Timeline
$0.0M
Cost

The New Doctrine: A Factory

High-certainty generation

🧠 SAE Explainability

Explore

AI Engineering

Engineering...

Validated & Patent-Ready

0.0 weeks
Timeline
$0.00M
Cost

The Transformation

We've replaced the needle-in-haystack approach with precision engineering. Every therapeutic candidate is designed for success, not discovered by chance.

🧬
Research

Try it live: Experience the complete drug development pipeline powered by AI. Select a stage above to run an interactive demo with real variants and see SAE explainability in action.

Research Use Only - Simulated Results
From Target Validation to Therapeutic Dossier (RUO)

Target Validation

Hereditary Breast Cancer Triage

Performance
95.7% ClinVar AUROC
Eliminates $2.1M target validation costs
API Pipeline
/predict_variant_impact/predict_protein_functionality_change/predict_chromatin_accessibility

Ready to Build Your Next Cancer Drug?

This demonstration will show you how to go from a genetic variant to a validated therapeutic target using our complete AI-powered drug development pipeline.

Research Use Only - Simulated Results

R&D ROI Calculator

Calculate Your R&D ROI Improvement

See exactly how CrisPRO's AI reduces failure costs and accelerates your pipeline.Real ROI calculations for biotech executives.

90%
Success Rate
72x
Faster Validation
$12M+
Annual Savings
6x
ROI Multiple
Biotech ROI Calculator

Calculate Your R&D ROI Improvement

See exactly how CrisPRO's AI reduces failure costs and accelerates your pipeline

🚀 Watch live simulation with industry data

Live ROI Simulation

Current Industry Reality
$20.0M/mo
R&D Investment
15%
Success Rate
10/year
Targets Validated
18mo
Validation Time
CrisPRO Transformation
95.7% AUROC
Oracle Accuracy
1 week
Validation Time
90% success
Target Success Rate
72x faster
Speed Improvement
CrisPRO Target Analysis

Target Validation Score

FAILVALID

+18,420

VALIDATED TARGET

Oracle AI validating therapeutic target in real-time

CrisPRO ROI Impact

Current Monthly Failures
$0K

Wasted on failed targets (85% failure rate)

Monthly Savings
Calculating...

Saved by reducing target validation failures

Success Rate
90%

vs 15% current (+0% improvement)

Validation Speed
0x faster

18 months → 1 week with Oracle AI

Annual ROI
0.0x

Return on CrisPRO investment ($2M/year)

What This Means for Your Pipeline:
Validate 0 more targets per year
De-risk 0 additional programs
95.7% accuracy vs 15% current
Focus wet-lab resources on validated targets only

Ready to Transform Your Numbers?

Schedule a demo to see how these savings apply to your specific programs

Eliminate the $2.6B gamble with mathematical certainty.

Join the biotech leaders who've eliminated the $2.6B gamble with mathematical certainty. Transform your R&D pipeline from gambling to engineering.